TNNT2 and coronary artery disorder: The incidence was 13.9 (95% CI 5.5–22.2) per 100 PYs in the CAD and elevated hs-cTnT group, which was much higher than that in the other three groups (range 2.0–3.5 per 100 PYs), and the clinical course was significantly worse in the CAD and elevated hs-cTnT group (log-rank P < 0.001).